Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Landewé

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Springer Seminars in Immunopathology|July 18, 2001
Spondylarthropathies: options for combination therapyA M van Tubergen, R B Landewé, S van der Linden
The European Respiratory Journal|December 24, 1998
Chylothorax or leakage of total parenteral nutrition?A Wolthuis, R B Landewé, P H Theunissen, et al.
Nature Medicine|July 8, 1999
Does cyclosporin A cause cancer?R B Landewé, B E van den Borne, F C Breedveld, et al.
Clinical and Experimental Rheumatology|December 10, 1999
Combination cyclosporine and (hydroxy)chloroquine in rheumatoid arthritisB A Dijkmans, R B Landewé, B E van den Borne, et al.
Lancet (London, England)|May 23, 2000
Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidityR B Landewé, B E van den Borne, F C Breedveld, et al.
The Journal of Rheumatology|September 1, 1992
Cyclosporine and chloroquine synergistically inhibit the interferon-gamma production by CD4 positive and CD8 positive synovial T cell clones derived from a patient with rheumatoid arthritisR B Landewé, A M Miltenburg, F C Breedveld, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 25, 1992
[No difference in effectiveness measured between treatment in a thermal bath and in an exercise bath in patients with rheumatoid arthritis]R B Landewé, R Peeters, R L Verreussel, et al.
Arthritis and Rheumatism|May 1, 1994
A randomized, double-blind, 24-week controlled study of low-dose cyclosporine versus chloroquine for early rheumatoid arthritisR B Landewé, H S Goei Thè, A W van Rijthoven, et al.
Scandinavian Journal of Rheumatology|January 1, 1996
Low dose cyclosporine in early rheumatoid arthritis: effective and safe after two years of therapy when compared with chloroquineB E van den Borne, R B Landewé, H S The, et al.
Rheumatology (Oxford, England)|May 18, 1999
Cyclosporin A therapy in rheumatoid arthritis: only strict application of the guidelines for safe use can prevent irreversible renal function lossB E van den Borne, R B Landewé, H S Goei The, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Springer Seminars in Immunopathology|July 18, 2001
Spondylarthropathies: options for combination therapyA M van Tubergen, R B Landewé, S van der Linden
The European Respiratory Journal|December 24, 1998
Chylothorax or leakage of total parenteral nutrition?A Wolthuis, R B Landewé, P H Theunissen, et al.
Nature Medicine|July 8, 1999
Does cyclosporin A cause cancer?R B Landewé, B E van den Borne, F C Breedveld, et al.
Clinical and Experimental Rheumatology|December 10, 1999
Combination cyclosporine and (hydroxy)chloroquine in rheumatoid arthritisB A Dijkmans, R B Landewé, B E van den Borne, et al.
Lancet (London, England)|May 23, 2000
Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidityR B Landewé, B E van den Borne, F C Breedveld, et al.
The Journal of Rheumatology|September 1, 1992
Cyclosporine and chloroquine synergistically inhibit the interferon-gamma production by CD4 positive and CD8 positive synovial T cell clones derived from a patient with rheumatoid arthritisR B Landewé, A M Miltenburg, F C Breedveld, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 25, 1992
[No difference in effectiveness measured between treatment in a thermal bath and in an exercise bath in patients with rheumatoid arthritis]R B Landewé, R Peeters, R L Verreussel, et al.
Arthritis and Rheumatism|May 1, 1994
A randomized, double-blind, 24-week controlled study of low-dose cyclosporine versus chloroquine for early rheumatoid arthritisR B Landewé, H S Goei Thè, A W van Rijthoven, et al.
Scandinavian Journal of Rheumatology|January 1, 1996
Low dose cyclosporine in early rheumatoid arthritis: effective and safe after two years of therapy when compared with chloroquineB E van den Borne, R B Landewé, H S The, et al.
Rheumatology (Oxford, England)|May 18, 1999
Cyclosporin A therapy in rheumatoid arthritis: only strict application of the guidelines for safe use can prevent irreversible renal function lossB E van den Borne, R B Landewé, H S Goei The, et al.
Pageof 3